Sort
15,842 grants matching “pancreatic cancer”
A Follow-up Study for Causes of Cancer in Black Women
$1,828,358Lynn Rosenberg · Boston University Medical Campus · U01 · FY2019 · CA
Surveillance, Epidemiology and End Results (SEER) - New Mexico
$1,827,870Charles L Wiggins · University Of New Mexico · N01 · FY2009 · CA
Thoracic and Gastrointestinal Malignancies Branch Clinical Core
$1,826,226Raffit Hassan · Division Of Basic Sciences - Nci · ZID · FY2018 · CA
Physical Activity, Energy Balance, and Cancer
$1,825,565Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
$1,822,547Sanku Mallik · North Dakota State University · P20 · FY2019 · GM
Hypoxia signaling in cancer development
$1,821,217Zhengping Zhuang · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Center for Applied Preclinical Research (CAPR)
$1,817,445Terry Van Dyke · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Integrated Immune Engineering for Poor Prognosis Cancers
$1,811,915David J Odde · University Of Minnesota · P01 · FY2024 · CA
NIA Confocal Imaging Facility
$1,811,264Fred Indig · National Institute On Aging · ZIC · FY2022 · AG
Molecular Mechanisms Of Growth Control And Carcinogenesis
$1,805,309J. Silvio Gutkind · National Institute Of Dental & Craniofacial Research · ZIA · FY2014 · DE
Heritable Neurodegenerative and Autoimmune Disorders
$1,800,797Anil B Mukherjee · Child Health And Human Development · Z01 · FY2007 · HD
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$1,800,107Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
$1,799,703William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2025 · CA
Center for Immunotherapeutic Transport Oncophysics
$1,797,348Haifa Shen · Methodist Hospital Research Institute · U54 · FY2020 · CA
A novel highly stable pancreatic enzyme replacement therapy to improve outcomes for patients with pancreatic insufficiency.
$1,796,643Robert Gallotto · Synspira Therapeutics, Inc. · R44 · FY2022 · DK
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
$1,794,624Ying Yuan · University Of Tx Md Anderson Can Ctr · U01 · FY2022 · DK
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models
$1,794,070Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Mechanisms of Inorganic Carcinogenesis
$1,786,280Michael Waalkes · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Pancreatic Cancer Detection Consortium
$1,783,224Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2018 · CA
Molecular Pathogenesis of the Hamartoma Syndromes
$1,781,629David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2016 · CA
Loma Linda University Center for Health Disparities Res*
$1,781,553Marino De Leon · Loma Linda University · P20 · FY2006 · MD
Molecular Pathogenesis of the Hamartoma Syndromes
$1,781,486David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2015 · CA
SPORE IN GASTOINTESTINAL CANCER
$1,781,425University Of Nebraska Medical Center · P50 · FY2001 · CA
Genetics and Biology of Pancreatic Duct Adenocarcinoma
$1,779,288Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2008 · CA
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$1,777,919Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA